Will The Biosimilars Industry Peak By 2020?
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite market-creation effects in EMs, government-backed ventures and non-traditional companies like Korea’s Samsung could fuel a hyper-commoditized biosimilars market that leads to a turning point around 2020, Nomura says.